The Gene Technology Regulator (the Regulator) as an independent officer can undertake a technical review of the regulations. The purpose of the review is to ensure the Gene Technology Regulations reflect current technology and scientific knowledge, so that new technologies are regulated in a manner commensurate with the risks they pose.
The Regulator consulted the public on a discussion paper published on the Office of the Gene Technology Regulator (OGTR) website outlining four options for how new technologies could be regulated under the gene technology regulatory scheme. The options range from full regulation to excluding some specific techniques from regulation.
The consultation closed on December 16 2016, and the Regulator is now considering which option to pursue. Those considerations will include the issues raised in submissions, scientific understanding, potential risks, the regulatory burden implications for stakeholders, whether regulatory burden would be commensurate with risks, and the policy intent of the GT Act.
Three of the options would require legislative change for implementation. If the Regulator decides this is necessary, there will be further public consultation on draft amendments before any legislative change occurs. If you want to ensure you are informed of any future consultations, please subscribe to OGTR News.
Your feedback has been submitted
Thank you for taking the time to provide feedback. It will be used to make improvements to this website.